Schedule 13G ownership disclosure
CARDIOME PHARMA CORP
Security class unavailable · CUSIP: 14159U301
Event date: 2018-04-30
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 4,149,244
- Percent of class
- 11.9000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001085146-18-001201
- Form type
- SC 13G
- Filer
- Correvio Pharma Corp.
- CIK
- CIK 1036141
- Filed
- May 02, 2018
- Reporting period
- Apr 30, 2018
- Description
- Schedule 13G beneficial ownership